Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28074940 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL506080 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL28258672 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL22588820 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL16594216 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL24981778 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL1760691 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL22588823 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL21118936 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 | |
| SCHEMBL28225342 | 1.00 | LMNA (0.65) | LMNADNM1TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| CN-102164849-B | Heterogeneous hydrogen-catalyst reactor | 辉光能源公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20110114075-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | LMNA 4529/4885DNM1 3850/4885TSHR 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.